BA
The Boeing Company
BA has the edge over BCHT overall, supported by stronger fundamentals and lower modeled downside.
BCHT
Birchtech Corp.
BCHT offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
BCHT Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Weak | |
| Strong |
BCHT's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA's PE is 18x, but its earnings don't support one, so it isn't a reliable read right now.
BCHT PE Valuation
BCHT has no meaningful PE right now: it lost money over the past year.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
BCHT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect BCHT's losses to shrink, with revenue growing.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has the edge over BCHT on earnings quality, reporting a profit while its opponent remains loss making.
BCHT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.19 | +$0.03 |
| Q2 2026 | -$0.13 | +$0.16 |
| Q1 2026 | -$0.12 | +$0.39 |
| Q4 2025 | -$0.16 | +$0.39 |
| Q3 2025 | -$0.22 | -$0.21 |
| Q2 2025 | -$0.29 | -$0.25 |
| Q1 2025 | -$0.51 | -313% |
| Q4 2024 | -$0.55 | -283% |
BCHT is still losing money, but far less than before: $0.19 per share over the past year, against $0.65 at its worst in early 2020.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over BCHT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA has the edge over BCHT on profitability, with a higher operating margin.
BCHT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.5M | -25% |
| Q2 2026 | $3.8M | +16% |
| Q1 2026 | $4.2M | +32% |
| Q4 2025 | $3.8M | -28% |
| Q3 2025 | $7.4M | +41% |
| Q2 2025 | $3.3M | -3.2% |
| Q1 2025 | $3.2M | -9.4% |
| Q4 2024 | $5.3M | +29% |
BCHT's revenue has slid since its 2022 peak: $6M last quarter, down 25% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -11% | -22 points |
| Q2 2026 | -43% | -6.4 points |
| Q1 2026 | -27% | +15 points |
| Q4 2025 | -35% | -27 points |
| Q3 2025 | 11% | +32 points |
| Q2 2025 | -36% | +70 points |
| Q1 2025 | -42% | +17 points |
| Q4 2024 | -7.5% | -239 points |
BCHT's operating margin was −11% last quarter, down 22 points from the same quarter a year ago.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over BCHT on cash generation, producing positive trailing cash flow while its opponent burns cash.
BCHT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$837.5K | -367% |
| Q2 2026 | -$2.9M | -$1.2M |
| Q1 2026 | -$2.2M | -$1.9M |
| Q4 2025 | $958.4K | +$1.9M |
| Q3 2025 | $314.2K | +$1.1M |
| Q1 2025 | -$268.5K | +$170.7K |
| Q4 2024 | -$937.8K | -105% |
| Q1 2024 | -$439.2K | -156% |
BCHT has burned cash in most quarters: −$5M over the past year, against −$3M the year before.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
BCHT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2024 | -1.6x | Net Cash |
| Q2 2024 | -1.7x | Net Cash |
| Q1 2024 | -1.4x | Net Cash |
| Q4 2023 | -3.2x | Net Cash |
BCHT has more cash than debt.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
BCHT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.9 | Neutral |
| Stochastic | 14.3 | Oversold |
BCHT's weekly RSI is 38 (neutral) and its Stochastic is 14 (oversold).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA is trading at 18x earnings, a 26% discount to the Industrials sector's median of 24x, though its earnings don't support one.
BCHT PE vs Industrials Sector
| Metric | BCHT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
BCHT has no meaningful PE right now: it lost money over the past year.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
BCHT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.28 | 8.6% below |
| 20 week MA | $1.41 | 17% below |
| 50 week MA | $2.15 | 46% below |
| 100 week MA | $2.58 | 55% below |
| 200 week MA | $2.86 | 59% below |
BCHT is in a downtrend: it's below all five of its weekly moving averages, and 59% below its 200-week average.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has the edge over BCHT on returns for 2026, with the stronger performance.
BCHT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $0.95 | $3.20 | +237% |
| 2021 | $3.20 | $2.90 | -9.4% |
| 2022 | $2.90 | $1.50 | -48% |
| 2023 | $1.50 | $4.60 | +207% |
| 2024 | $4.60 | $2.45 | -47% |
| 2025 | $2.45 | $3.75 | +53% |
| 2026 YTD | $3.75 | $1.17 | -69% |
BCHT's yearly returns have swung widely, from +237% in 2020 to −48% in 2022. It's down 69% so far in 2026.